Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 17.6% – What’s Next?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price traded up 17.6% during mid-day trading on Monday . The company traded as high as C$0.20 and last traded at C$0.20. 134,500 shares were traded during mid-day trading, a decline of 48% from the average session volume of 256,409 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 5.9 %

The firm has a fifty day simple moving average of C$0.16 and a 200 day simple moving average of C$0.10. The company has a debt-to-equity ratio of 4.23, a quick ratio of 0.84 and a current ratio of 0.10. The company has a market cap of C$27.27 million, a PE ratio of -16.84 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.